CD8A and metabolic dysfunction-associated steatohepatitis: The depletion of CD8+ T cells using anti-CD8 antibodies reduced the level of liver inflammation markers (ALT), macrophage infiltration, and fibrosis markers (αSMA, col1a1), directly indicating the detrimental role of CD8+ T cells in MASH.